跳至主要内容
临床试验/ACTRN12613000120774
ACTRN12613000120774已完成2 期

Can ginger ameliorate chemotherapy-induced nausea? A double blind, randomised placebo controlled feasibility study.

The University of Queensland0 个研究点目标入组 77 人开始时间: 2013年1月31日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * Chemotherapy-naive cancer patients receiving treatment of any emetogenicity.
  • ( Previously experienced CINV symptoms in >=1 chemotherapy cycle.
  • * >18 years .
  • * Life expectancy >3 months.
  • * Baseline Karnofsky > 60.
  • * No concurrent neoplasms or illness inducing nausea independent of chemotherapy
  • * No self-prescribed therapies for nausea.
  • * Receiving moderate or highly emetogenic chemotherapy treatment.
  • * Receiving 5HT3 antagonist.

排除标准

  • The following exclusion criteria will apply:
  • * Patients requiring radiotherapy.
  • * Pregnant or lactating.
  • * Concurrent use of other ginger-containing supplements and ingestion of large quantities of ginger.
  • * History of adverse reactions to ginger.
  • * Patients with malignancies of gastrointestinal tract/gastrointestinal diseases or nausea and vomiting due to reasons other than chemotherapy.
  • * Thrombocytopenia or patients undergoing chemotherapy that is likely to cause thrombocyopenia (<50 x 10^9/L).
  • * Currently prescribed warfarin or on anti-coagulant therapy.

研究者

相似试验

Can ginger ameliorate chemotherapy-induced nausea? A... | 临床试验